Opinion | From AI to EVs, China’s tech genius is in making it cheap and accessible

Opinion | From AI to EVs, China’s tech genius is in making it cheap and accessible

Technological dominance was once synonymous with proprietary innovations. But recent history suggests differently: true disruption comes from making technology cheap, accessible and inescapable. China rejects the traditional high-cost, high-margin model of innovation. While foundational artificial intelligence (AI) and biotechnological breakthroughs still largely originate in the United States, China excels at rapidly scaling up and optimising…

Read More
Jim Cramer Says Merck & Co., Inc. (MRK) ‘Needs To Have China Be Less Of Our Enemy’

Is This Healthcare Stock A Good Buy?

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other healthcare stocks. Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential,…

Read More
Bristol Myers Squibb stock rises, Merck moves lower. Here's why.

Bristol Myers Squibb stock rises, Merck moves lower. Here’s why.

Pharmaceutical giant Bristol Myers Squibb (BMY) raises its full-year earnings guidance after topping third quarter estimates, sending shares higher in pre-market trading. Concurrently, Merck & Co. (MRK) lowered its sales outlook despite topping third quarter estimates, sending the stock lower. Julie Hyman and Brad Smith report more on these two pharma companies’ earnings results tied…

Read More